Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (91-100 of 284) with videos related to

Pageof 29
Sort By:
Pharmacology & Therapeutics|November 16, 2007
Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspectsMagnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, et al.
Scientific Reports|January 16, 2024
Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid modelSara Redenšek Trampuž, Sander van Riet, Åsa Nordling, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2011
The ligands of estrogen receptor α regulate cytochrome P4502C9 (CYP2C9) expressionJessica Mwinyi, Isa Cavaco, Begum Yurdakok, et al.
Molecular Pharmaceutics|July 5, 2013
An integrated in vitro model for simultaneous assessment of drug uptake, metabolism, and effluxEtienne P A Neve, Per Artursson, Magnus Ingelman-Sundberg, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 29, 2018
Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined ConditionsSabine U Vorrink, Yitian Zhou, Magnus Ingelman-Sundberg, et al.
Drug Discovery Today|April 3, 2009
In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part I: Beyond the reduction of animal model useLucie Huynh, Rosalinde Masereeuw, Thomas Friedberg, et al.
FEBS Letters|January 21, 2016
Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1Jia Guo, Stefanie Thiess, Inger Johansson, et al.
Archives of Toxicology|November 9, 2020
Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolismTomas Smutny, Lucie Hyrsova, Albert Braeuning, et al.
Journal of Neurochemistry|October 23, 2002
The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cellsAnastasia Simi, Margareta Porsmyr-Palmertz, Anna Hjertén, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 28, 2009
Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture modelYlva Edling, Louise K Sivertsson, Angelica Butura, et al.
Pageof 29

Showing results (91-100 of 284) with videos related to

Sort By:
Pageof 29
Pharmacology & Therapeutics|November 16, 2007
Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspectsMagnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, et al.
Scientific Reports|January 16, 2024
Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid modelSara Redenšek Trampuž, Sander van Riet, Åsa Nordling, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2011
The ligands of estrogen receptor α regulate cytochrome P4502C9 (CYP2C9) expressionJessica Mwinyi, Isa Cavaco, Begum Yurdakok, et al.
Molecular Pharmaceutics|July 5, 2013
An integrated in vitro model for simultaneous assessment of drug uptake, metabolism, and effluxEtienne P A Neve, Per Artursson, Magnus Ingelman-Sundberg, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 29, 2018
Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined ConditionsSabine U Vorrink, Yitian Zhou, Magnus Ingelman-Sundberg, et al.
Drug Discovery Today|April 3, 2009
In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part I: Beyond the reduction of animal model useLucie Huynh, Rosalinde Masereeuw, Thomas Friedberg, et al.
FEBS Letters|January 21, 2016
Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1Jia Guo, Stefanie Thiess, Inger Johansson, et al.
Archives of Toxicology|November 9, 2020
Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolismTomas Smutny, Lucie Hyrsova, Albert Braeuning, et al.
Journal of Neurochemistry|October 23, 2002
The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1beta signalling but not its biosynthesis in rat cortical glial cellsAnastasia Simi, Margareta Porsmyr-Palmertz, Anna Hjertén, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 28, 2009
Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture modelYlva Edling, Louise K Sivertsson, Angelica Butura, et al.
Pageof 29